Bought
Maintained
Sold
Other funds holding BXC
VC
PAIM
GJL
JCP
NC
Axa's BXC Position: Q2 2023 in Review
Axa sold out of BlueLinx (BXC) in Q2 2023, closing a stake of 12,500 shares — an estimated $850K sold.
Axa first reported a position in BXC in Q2 2018 and held it in 7 quarters. The position peaked at $1.19M in Q2 2018. 168 funds tracked by Wall St. Rank hold BXC as of Q2 2023.
- Axa reported no remaining BlueLinx position as of Q2 2023 after selling out during the quarter.
- Axa sold 12,500 BlueLinx shares in Q2 2023, an estimated $850K.
- Axa first reported a position in BlueLinx in Q2 2018 and held it in 7 quarters.
- Axa's BlueLinx position peaked at $1.19M in Q2 2018.
- 168 funds tracked by Wall St. Rank held BlueLinx as of Q2 2023.
Based on Axa's 13F filing for Q2 2023, filed 14 Aug 2023.